Last update 07 Nov 2025

The Board of Regents of The University of Texas System

Subsidiary Company|Texas, United States|
www.utsystem.edu

Overview

Tags

Neoplasms
Other Diseases
Nervous System Diseases
Small molecule drug
Bispecific antibody
Antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms26
Nervous System Diseases11
Immune System Diseases10
Infectious Diseases8
Endocrinology and Metabolic Disease8
Hemic and Lymphatic Diseases6
Top 5 Drug TypeCount
Small molecule drug13
Monoclonal antibody5
Antibody3
Bispecific antibody3
AAV based gene therapy3
Top 5 TargetCount
GJA1(Gap junction alpha-1 protein)2
Eph(Ephrin receptor)2
CD molecules x TCRs2
TCTP(tumor protein, translationally-controlled 1)1
SIRT6(NAD-dependent protein deacetylase sirtuin-6)1

Related

39
Drugs associated with The Board of Regents of The University of Texas System
WO2024081789
Patent Mining
Target
KDM4
Mechanism
KDM4 inhibitors
Active Org.
The Board of Regents of The University of Texas System
Originator Org.
The Board of Regents of The University of Texas System
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
WO2024097602
Patent Mining
Target
LEMD2
Mechanism-
Active Org.
The Board of Regents of The University of Texas System
Originator Org.
The Board of Regents of The University of Texas System
Active Indication
Heart Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
WO2024073282
Patent Mining
Target
NSD1 x Nuclear receptor
Mechanism
NSD1 modulators
Active Org.
The Board of Regents of The University of Texas System
Originator Org.
The Board of Regents of The University of Texas System
Active Indication
Hypertension [+2]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with The Board of Regents of The University of Texas System
Login to view more data
0 Patents (Medical) associated with The Board of Regents of The University of Texas System
Login to view more data
100 Deals associated with The Board of Regents of The University of Texas System
Login to view more data
100 Translational Medicine associated with The Board of Regents of The University of Texas System
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
39
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
WO2025227116
 ( Eph )Patent Mining		Nervous System Diseases
More
Discovery
WO2024163499
 ( CD276 )Patent Mining		Nervous System Diseases
More
Discovery
WO2025174889
 ( BTK x MALT1 )Patent Mining		Hemic and Lymphatic Diseases
More
Discovery
WO2024092083
 ( Eph )Patent Mining		Nervous System Diseases
More
Discovery
WO2024233299
 ( CD molecules x TCRs )Patent Mining		Female Urogenital Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free